List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 346 studies with search of:   Ireland
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
2 Completed BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Copaxone
3 Completed Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: GW679769;   Drug: Dexamethasone;   Drug: Ondansetron Hydrochloride
4 Recruiting Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: YM178;   Drug: Tolterodine 4 mg;   Drug: Placebo
5 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
6 Recruiting Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: epoetin beta;   Drug: prednisone
7 Active, not recruiting Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: capecitabine;   Drug: cetuximab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
8 Recruiting Creating a Proficiency-Based Virtual Reality Simulation Training Programme for Laparoscopic Assisted Colectomy
Condition: Colorectal Disease
Interventions: Other: Proficiency-based virtual reality simulation training;   Other: Training under the current surgical training programme
9 Completed Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
Conditions: Coronary Arteriosclerosis;   Diabetes Mellitus, Type 2;   Cerebrovascular Accident;   Dyslipidemia;   Peripheral Vascular Disease
Intervention: Drug: Atorvastatin (Lipitor)
10 Recruiting GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Condition: Tumor Antigen-Positive Non-Small Cell Lung Cancer
Intervention: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic
11 Completed Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
Conditions: Abscess;   Wound Infection;   Diabetic Foot;   Ulcer;   Infection
Interventions: Drug: Moxifloxacin intravenous and per os;   Drug: Piperacillin/Tazobactam intravenous, Amoxicillin/Clavulanic acid per os
12 Active, not recruiting Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer;   Advanced Breast Cancer
Interventions: Drug: Letrozole;   Drug: Lapatinib (GW572016)
13 Recruiting Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
Condition: Breast Cancer
Intervention: Drug: anastrozole
14 Completed Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Cancer;   Breast Cancer
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
15 Active, not recruiting Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: triptorelin;   Procedure: radiation therapy
16 Completed Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Casopitant (GW679769) oral tablets;   Drug: Casopitant (GW679769) intravenous;   Drug: Dexamethasone intravenous;   Drug: Ondansetron oral tablets
17 Recruiting A 5-Year Registry Study of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Condition: Crohn's Disease
Intervention: Drug: adalimumab
18 Recruiting This Study Plans to Assess the Response of PAD Treatment to VAD or VAD-Like Treatment in Patients Who Have Relapsed or Refractory Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Velcade
19 Completed CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE With An Adjustable Maintenance Dose Of SYMBICORT
Condition: Asthma
Intervention: Drug: Salmeterol/fluticasone propionate or formoterol/budesonide
20 Recruiting ALTTO(Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation)Study; BIG 2-06/N063D
Condition: Breast Cancer
Intervention: Drug: Lapatinib

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services